I agree that this site is using cookies. You can find further informations here.
X
Manvelian, Garen
82  results:
Search for persons X
?
1

Safety of the PCSK9 inhibitor alirocumab: insights from 47 ..:

Goodman, Shaun G ; Steg, Philippe Gabriel ; Szarek, Michael...
European Heart Journal - Cardiovascular Pharmacotherapy.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Effect of proprotein convertase subtilisin/kexin type 9 inh..:

Mohammadi, Kusha A. ; Brackin, Taylor ; Schwartz, Gregory G....
Cancer Medicine.  12 (2023)  16 - p. 16859-16868 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Correction: Effect of alirocumab on cataracts in patients w..:

Suc, Gaspard ; Schwartz, Gregory G. ; Goodman, Shaun G....
BMC Ophthalmology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab ..:

Goodman, Shaun G. ; Steg, Philippe Gabriel ; Poulouin, Yann...
Journal of the American Heart Association.  12 (2023)  18 - p. , 2023
Link: https://doi.org/10.1161/..
 
?
5

Transiently achieved very low LDL-cholesterol levels by sta..:

Schwartz, Gregory G ; Szarek, Michael ; Bhatt, Deepak L...
European Heart Journal.  , 2023
Link: https://doi.org/10.1093/..
 
?
6

Pharmacologic and Genetic Downregulation of Proprotein Conv..:

Lawler, Patrick R. ; Manvelian, Garen ; Coppi, Alida...
Critical Care Explorations.  5 (2023)  11 - p. e0997 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Effect of alirocumab on cataracts in patients with acute co..:

Suc, Gaspard ; Schwartz, Gregory G. ; Goodman, Shaun G....
BMC Ophthalmology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
8

Pharmacogenomic Study of Statin-Associated Muscle Symptoms ..:

Murphy, William A. ; Lin, Nan ; Damask, Amy...
Circulation: Genomic and Precision Medicine.  15 (2022)  3 - p. , 2022
Link: https://doi.org/10.1161/..
 
?
9

Relation of red blood cell distribution width to risk of ma..:

Moriarty, Patrick M. ; Steg, Philippe Gabriel ; McGinniss, Jennifer...
Journal of Clinical Lipidology.  16 (2022)  5 - p. 747-756 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Efficacy and Safety of Alirocumab in Children and Adolescen..:

Bruckert, Eric ; Caprio, Sonia ; Wiegman, Albert...
Arteriosclerosis, Thrombosis, and Vascular Biology.  42 (2022)  12 - p. 1447-1457 , 2022
Link: https://doi.org/10.1161/..
 
?
11

Apolipoprotein B, Residual Cardiovascular Risk After Acute ..:

Hagström, Emil ; Steg, P. Gabriel ; Szarek, Michael...
Circulation.  146 (2022)  9 - p. 657-672 , 2022
Link: https://doi.org/10.1161/..
 
?
12

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients ..:

Schwartz, Gregory G. ; Szarek, Michael ; Bittner, Vera A....
Journal of the American College of Cardiology.  78 (2021)  5 - p. 421-433 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Alirocumab treatment and neurocognitive function according ..:

Janik, Matthew J. ; Urbach, Dorothea V. ; van Nieuwenhuizen, Elane...
Atherosclerosis.  331 (2021)  - p. 20-27 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Efficacy and safety of alirocumab in statin-intolerant pati..:

Moriarty, Patrick M. ; Thompson, Paul D. ; Cannon, Christopher P....
Journal of Clinical Lipidology.  14 (2020)  1 - p. 88-97.e2 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Corrigendum to PCSK9 inhibition with alirocumab in pediatri..:

Daniels, Stephen ; Caprio, Sonia ; Chaudhari, Umesh...
Journal of Clinical Lipidology.  14 (2020)  5 - p. 741 , 2020
Link: https://doi.org/10.1016/..
 
1-15